Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × aumolertinib × Clear all

Phase

Phase 3 5 Phase 2 2 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Propofol 8 Sevoflurane 6 Dexamethasone 6 Rituximab 5 Magnetic Resonance Spectroscopy 5 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 Bevacizumab 4 Trastuzumab 3 Surgical Procedures, Operative 3 Standard of Care 3 Specimen Handling 3 Saline Solution 3 Metformin 3 Lenalidomide 3 Gemcitabine 3 Fluorouracil 3 Enoxaparin 3 Carboplatin 3 Acetaminophen 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 semaglutide 2 ribociclib 2 polyethylene glycol 3350 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡